<ѻý>Dapagliflozin: More Good News in HFѻý> SGLT-2 inhibitor advantage in DAPA-HF extended across T2D status, ARNI use Sep 19, 2019
<ѻý>Shared Decision-Making: Cardiologists Moving Through the Stages of Griefѻý> Rules from CMS for ICDs, LAA closure feels arbitrary, some say Sep 16, 2019
<ѻý>Patiromer Helps CKD Patients Stay on Spironolactoneѻý> Now the question is: Can outcomes be improved? Sep 15, 2019
<ѻý>Study: LVAD Surgical Technique Can be Further Refinedѻý> Left ventricular assist device outflow cannula angulation, anastomosis size may be important Sep 15, 2019
<ѻý>Debate: Is LVEF Really that Important in Heart Failure?ѻý> Benefit of identifying preserved, reduced, mid-range, supranormal EF under question Sep 14, 2019
<ѻý>Post-MI Survival Better With ICD for Some, Troubled Trial Suggestsѻý> Potential benefit in STEMI survivors with severe LV dysfunction, other risk factors soon after PCI Sep 04, 2019
<ѻý>MITRA-FR Inches in Line With COAPT at 2 Years Despite Contradictory Findingsѻý> More evidence that the two trials are more concordant than previously thought Sep 02, 2019
<ѻý>Dapagliflozin Benefits HFrEF Outcomes, Even Without Diabetesѻý> DAPA-HF trial affirms similar benefit to diabetes drug regardless of type 2 diabetes status Sep 01, 2019 video
<ѻý>Entresto Signals Expansion Into 'Gray Zone' of HFpEFѻý> PARAGON-HF may have missed overall, but HF docs see reason for hope Sep 01, 2019
<ѻý>STICH: CABG Survival Benefit Doesn't Hinge on Myocardial Viabilityѻý> Is viability testing now unnecessary for CAD patients with low LVEF? Aug 21, 2019
<ѻý>There Is Such Thing as a Too-High LVEFѻý> Study suggests sweet spot and proposes fourth left ejection phenotype Aug 07, 2019
<ѻý>ATTR Cardiomyopathy: 'Red Flags' for Screeningѻý> Consensus group highlights eight things to look for Jul 11, 2019
<ѻý>Entresto Out-of-Pocket Costs Out of Control?ѻý> Study highlights one reason for "sluggish" uptake Jul 10, 2019
<ѻý>Carpal Tunnel Syndrome: 'Red Flag' for Subsequent ATTR, Heart Failureѻý> Goal is to catch cardiac amyloidosis early, clinicians say Jul 01, 2019
<ѻý>Another Tricuspid Repair System Shows Promiseѻý> Device is designed for individual leaflet capture Jun 17, 2019
<ѻý>Low-Risk TAVR: Listen to the Echo Parametersѻý> Smaller annuli may benefit more from transcatheter valves Jun 17, 2019
<ѻý>Makeover for TAVR Valves: Lower Profiles, Better Sealingѻý> Design features suggest several possibilities for improvement over current devices Jun 14, 2019
<ѻý>TAVR in Low-Risk Patients: Meta-Analyses Have Their Sayѻý> Improved outcomes overall, but not without downsides Jun 14, 2019
<ѻý>Pricey Brain Protection Devices of Questionable Value in TAVRѻý> Can TAVR programs survive using filters, deflectors in every case? Jun 13, 2019
<ѻý>No Added CV Risk for Oral Semaglutide in T2Dѻý> Safety study buffs resume for oral GLP-1 receptor agonist Jun 11, 2019
<ѻý>Slicer Seen Boosting Leaflet Mobility in Aortic Stenosisѻý> Study shows feasibility of novel treatment for calcified aortic stenosis May 24, 2019
<ѻý>TAVR Access Closure Devices Not Equal, Study Showsѻý> Separate study suggests bleed monitoring device could help May 23, 2019
<ѻý>New Device Lets TAVR Treat Aortic Regurgitationѻý> Early data favor newer-generation device May 23, 2019
<ѻý>MitraClip-Like Procedure Promising for Tricuspid Regurgitationѻý> Milder regurgitation, quality-of-life improvements seen at 30 days May 22, 2019
<ѻý>His Pacing Not Better Than BiV in First Head-to-Head Trialѻý> But small pilot may not be enough to 'dis the His' May 14, 2019
<ѻý>Tissue-Selective Afib Ablation; ED Drug for HF? Pacemaker Warningѻý> Recent developments of interest in cardiovascular medicine May 13, 2019
<ѻý>LVAD-Related GI Bleeding: Another Reason to Take Heart Failure Drugsѻý> Dose-response relationship seen Apr 08, 2019
<ѻý>Aortic Stenosis: Watchful Waiting Works Only for So Longѻý> Study supports timely aortic valve replacement in asymptomatic patients Mar 22, 2019
<ѻý>Bicuspid Anatomy Not Necessarily a Disadvantage for TAVRѻý> Do these registry findings warrant a randomized trial? Mar 18, 2019
<ѻý>HeartMate 3: 'A Much More Forgiving Pump'ѻý> Final data from MOMENTUM 3 still shine for safety Mar 18, 2019
<ѻý>Glowing Reviews for Low-Risk TAVR Trials at ACCѻý> But is TAVR really the right procedure for every AS patient going forward? Mar 17, 2019
<ѻý>Low-Risk TAVR at Least as Good as Surgery in Pivotal Trialsѻý> Evolut, PARTNER 3 trials called "game changers" Mar 16, 2019 video
<ѻý>Low-Risk TAVR in Spotlight at ACCѻý> Prevention guidelines, Apple Watch also on parade in New Orleans Mar 14, 2019
<ѻý>Leaflet Laceration Promising to Prevent Valve Complicationsѻý> New techniques tackle obstruction risk in TMVR, TAVR Mar 04, 2019
<ѻý>Autologous Blood Use Better for Cardiac Surgeries?ѻý> Intra-operative strategy associated with fewer post-op transfusions, shorter stays Jan 28, 2019
<ѻý>Will Biomarkers Eventually Replace Physicians?ѻý> Milton Packer imagines the end of nonprocedural medicine as we know it Jan 16, 2019
<ѻý>The Best Cardiovascular Drug Many Physicians Won’t Prescribeѻý> Milton Packer describes the rise and fall of one of our most effective medicines Dec 19, 2018
<ѻý>Severe COPD, Heart Failure a Bad Comboѻý> Symptoms of undertreated HF are too often confused with COPD Dec 14, 2018
<ѻý>ARNI on Par With Other HFrEF Strategies for Saving Lives Long Termѻý> Sacubitril/valsartan yields "comparable" number needed to treat at 5 years Nov 29, 2018